FindTrial
Sign In

Clinical Efficacy of Ashwagandhadi Granules on Prevention of childhood morbidity Childhood Morbidity

Clinical Evaluation of Ashwagandhadi Granules on Childhood Morbidity

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046570
Enrollment
60
Registered
2022-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children not suffering from acute / chronic or life threatening disorders i.e. Healthy Children. Properly Immunised children with routine vaccination (NIP).

Exclusion criteria

Exclusion criteria: Children age below 1 year and more than 5 years. Children infected with COVID 19 Any severe systemic illness Congenital malformations. Herediatory disease Inborn error of metabolism Chronic illness. Not accepting orally

Design outcomes

Primary

MeasureTime frame
Symptomatic scale CBC ESR Throat swab X ray Chest PA view Covid RTPCRTimepoint: one month—

Secondary

MeasureTime frame
Cough Dyspnoea Chest pain Nature of Phlegm Nasal congestion Rhinorrhea Wheezing/Rhonchi Fever Headache Sore throat Fatigue Abdominal Pain Diarrhea Vomiting AppepiteTimepoint: 3 follow up will be done at 10th day, 20th day and 30th day.—

Countries

India

Contacts

Public ContactDr P S Upadhyay

Banaras Hindu University

psupadhyay08@gmail.com7355422083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026